- Directa Plus said it had been granted a patent relating to the company's unique manufacturing process, by the United States Patent and Trademark Office.

The new US patent covers Directa Plus' process for manufacturing graphene nanoplatelets using a water-based exfoliation technology.

'The manufacturing process allows the Company to engineer a wide range of particle morphologies that can be tailored to the particular requirements of end-user customers,' the company said. 'In addition, the 100 per cent production yield means that Directa Plus can manufacture products in large volumes at attractive price'

'This provides a significant competitive advantage, enabling the Company to integrate effectively and quickly with customers' large supply chains.'

At 9:43am: [LON:DCTA] Directa Plus Plc share price was +1p at 84p

Story provided by